$Corbus(CRBP)$CRBP FDA Grants Fast Track Designation to Nectin-4 Targeting ADC CRB-701 in Head and Neck Squamous Cell Carcinoma#Seeking# #biotech#引进自中国,快速通道。这个靶点不少国内企业做。争取做出一个BIC$石药集团(01093)$ $新诺威(SZ300765)$